Showing 3531-3540 of 8741 results for "".
- Resilia Pharmaceuticals Announces Return to Market of Neosalus Cream and Neosalus Lotionhttps://practicaldermatology.com/news/resilia-pharmaceuticals-announces-return-to-market-of-neosalus-cream-and-neosalus-lotion/2461697/Resilia Pharmaceuticals, Inc.’s Neosalus Cream and Neosalus Lotion are back. These products had not been available due to supply chain disruptions that occurred as a result of the COVID-19 public health crisis. Both Neosalus Lotion and Neosalus Cream use paten
- Cytrellis Taps New CTOhttps://practicaldermatology.com/news/cytrellis-taps-new-cto/2461695/Dr. Shiv Sabesan is Cytrellis Biosystems’ Chief Technology Officer. In his new role, Dr. Sabesan will lead the company's strategy as it continues to advance its proprietary ellacor Micro-Coring technology and expand indications. The technology was
- Dr. Suneel Chilukuri Named Hydrinity Accelerated Skin Science’s Chief Medical Advisorhttps://practicaldermatology.com/news/dr-suneel-chilukuri-named-hydrinity-accelerated-skin-sciences-chief-medical-advisor/2461692/Suneel Chilukuri, MD, is Hydrinity Accelerated Skin Science’s new Chief Medical Advisor. In this role, Dr. Chilukuri will chair the Hydrinity Accelerated Skin Science Medical Advisory Board. He will aid product development as well as develop and oversee all clinica
- Aquavit News: Company Files Investigational New Drug Application for Dermatoxhttps://practicaldermatology.com/news/aquavit-news-company-files-investigational-new-drug-application-for-dermatox/2461687/Aquavit has filed an Investigational New Drug Application with the U.S Food and Drug Administration (FDA) for Dermatox (aqubotulinumtoxinA), their intradermal injection of botulinum toxin. AqubotulinumtoxinA has already received regulatory approvals in Asia, Sou
- Galderma's Sculptra Now FDA Approved for Cheek Wrinkleshttps://practicaldermatology.com/news/galdermas-sculptra-now-fda-approved-for-cheeks/2461683/The U.S. Food and Drug Administration (FDA) has approved Sculptra (injectable poly-L-lactic acid (PLLA-SCA)) for the correction of fine lines and wrinkles in the cheek area. Sculptra is the first FDA-approved PLLA collagen stimulator that helps stimulate natural collagen production in the
- La Roche-Posay Gives Back: Brand Offers Free Public Screenings in NYChttps://practicaldermatology.com/news/la-roche-posay-gives-back-brand-offers-free-public-screenings-in-nyc/2461678/La Roche-Posay is kicking off Melanoma Awareness Month with free public skin cancer screenings at Hudson Yards on Sunday, April 30th and Monday, May 1st. On Sunday, April 30th and Monday, May 1st (Melanoma Monday,) La Roche-Posay, in partners
- Maintaining Normal Vitamin D Levels May Benefit Melanoma Patients on Immunotherapyhttps://practicaldermatology.com/news/maintaining-normal-vitamin-d-levels-may-benefit-melanoma-patients-on-immunotherapy/2461677/Patients with advanced skin cancer should make extra efforts to maintain normal vitamin D levels when receiving immune checkpoint inhibitors, according to a study in
- Cynosure Taps New CEOhttps://practicaldermatology.com/news/cynosure-taps-new-ceo/2461676/Nadav Tomer is Cynosure’s new chief executive officer, effective May 1, 2023. He succeeds Todd Tillemans, who will step down and will work closely with Mr. Tomer to ensure a smooth transition. "Nadav has an incredibly strong track record of operation
- Incyte Scores Vitiligo Nod for Opzelura Cream in Europehttps://practicaldermatology.com/news/incyte-scores-nod-for-opzelura-cream-for-vitiligo-in-europe/2461674/The European Commission (EC) has granted a marketing authorization for Opzelura (ruxolitinib) cream15mg/g for the treatment of non-segmental vitiligo with facial involvement in adults and adolescents from 12 years of age. The selective JAK1/JAK2 inhibi
- News You Can Use: AARS Extends Deadline for Research Grant Applicationshttps://practicaldermatology.com/news/news-you-can-use-aars-extends-deadline-for-research-grant-applications-1/2461672/The American Acne and Rosacea Society is extending the deadline to apply for an AARS Clinical Research Award ($10K) or the AARS Research Scholar Award ($75K). The new application deadline is Friday, April 28, 2023. Applications are available online at acneandrosacea.org/